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Montaner et al., 2007). It would be 
interesting and important to determine 
whether Cv-pdg-NLS-TAT repaired 
this type of DNA damage as well. This 
enzyme may not have a direct effect on 
the repair of oxidative DNA damage, but 
it may contribute to an overall upregula-
tion of repair mechanisms in the nuclear 
environment.
Because NMSCs continue to be a 
major health and economic issue, the 
development of new treatment and pre-
ventive modalities is crucial. In addi-
tion to standard recommendations such 
as sun avoidance and the application 
of sunscreen, there are promising treat-
ments and preventive therapies on the 
horizon. Cv-pdg-NLS-TAT may be one 
such modality; future clinical studies will 
further define its efficacy and tolerability.
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Peeling Skin Syndrome:  
Genetic Defects in Late Terminal 
Differentiation of the Epidermis
Paul E. Bowden1
In this issue, Israeli and colleagues confirm that homozygous mutations in 
corneodesmosin (CDSn) cause type B peeling skin syndrome (PSS), an auto somal 
recessive skin disorder. The deletion mutation described resulted in a frame-
shift, producing a downstream premature stop codon and early truncation of the 
protein. The recently described CDSn nonsense mutation in another PSS family 
also resulted in protein truncation and nonsense-mediated mRnA decay. Type B 
generalized PSS can now be clearly distinguished from acral PSS, caused by muta-
tions in transglutaminase 5. This directly affects cornified envelope cross-linking 
rather than corneodesmosome adherence. These observations provide new 
insight into the molecular defects underlying two closely related forms of PSS.
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PSS
Peeling skin syndrome (PSS), first 
described in the early twentieth century 
(Fox, 1921), is a rare cutan eous geno-
dermatosis that is classified into two 
forms: acral PSS (APSS; OMIM 609796) 
and generalized PSS (OMIM 270300). 
Although it has been suggested (Traupe, 
1989) that the generalized form can 
be further subdivided into noninflam-
matory (type A) and inflammatory 
(type B), other phenotypes including 
those with hair and nail abnormal-
ities have also been described, further 
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complicating the genetics. All three 
major types present as autosomal reces-
sive conditions and all are characterized 
by superficial peeling (exfoliation or 
shedding) of the upper epidermis (Levy 
and Goldsmith, 1982). Ultrastructural 
investigation (Brusasco et al., 1998; 
Hashimoto et al., 2000) indicates that 
the split occurs between the junction 
of the stratum corneum and the granu-
lar layer (stratum granulosum), focus-
ing recent attention on the processes 
involved in late epidermal differentia-
tion to explore a molecular explanation 
for these rare conditions.
aPSS
The acral form of peeling skin syn-
drome, as the name suggests, involves 
mainly palmar and plantar skin. 
Genome-wide linkage analysis in 
two unrelated APSS families (Cassidy 
et al., 2005) localized the genetic 
defect to a 10.2-Mb region on chro-
mosome 15 (at 15q15.2). Further fine 
mapping implicated a small region 
containing nine genes with a small 
transglutaminase (TGM) gene cluster 
(containing TGM5, TGM7, and EPB42) 
at its center. However, only TGM5 had 
strong expression in the skin; further-
more, this enzyme was localized to the 
region between the granular layer and 
the stratum corneum, precisely where 
the split occurs in APSS. This enzyme is 
responsible for introducing γ-glutamyl–
ε-lysine isopeptide bonds into the 
structural proteins (e.g., loricrin, 
involucrin, small proline-rich proteins) 
of the cornified envelope and corneo-
cyte. TGM5 spans 33.7 kb of genomic 
DNA and contains 13 exons, which 
encode two splice variants. Sequencing 
of all 13 exons and splice sites revealed 
the same two homozygous missense 
mutations (p.T109M and p.G113C) in 
all affected individuals in both APSS 
families. However, the molecular 
pathology appeared to be due solely to 
the p.G113C mutation, which reduced 
TG5 enzyme levels to zero (Cassidy 
et al., 2005). More recently, another 
report of a Tunisian family with APSS 
confirmed the involvement of TGM5 
gene mutations and another patho-
genic variant, a homozygous missense 
mutation in exon 8 (p.K445N), was 
identified (Kharfi et al., 2009).
Inflammatory generalized PSS
Detailed studies of inflammatory gener-
alized PSS (type B) followed the success 
with APSS, but although the pathology 
was similar and, like APSS, showed cer-
tain similarities to Netherton syndrome 
(NS; Geyer et al., 2005), screening of the 
TGM5 gene and the gene responsible 
for NS (SPINK5) revealed no sequence 
alterations in this condition. Thus, 
another candidate gene was impli-
cated, and this was revealed using the 
same technology as for APSS. Whole-
genome linkage analysis was performed 
on a large family with four affected 
individuals using a chip-based single-
nucleotide polymorphism approach 
(Oji et al., 2010). The histopathology 
and ultrastructure showed a subcorneal 
split characteristic of PSS, and genotyp-
ing using an Affymetrix GeneChip array 
(250 K) identified a candidate region 
on chromosome 6p. Refined mapping 
produced a LOD score of 5.4 (>3 being 
significant) to a 5.7-Mb region of DNA 
at 6p21.3, which contained 195 genes. 
One of the genes in this region encod-
ed corneodesmosin (CDSN), a special-
ized component of corneodesmosomes 
that play an important role in maintain-
ing stratum corneum structural integ-
rity. This seemed an ideal candidate 
gene and sequencing quickly revealed 
that all four patients with PSS had the 
same homozygous missense mutation 
(p.K59X), resulting in a premature stop 
codon at the beginning of the tran-
script. Real-time PCR indicated that 
75% of the corneo desmosin mRNA was 
missing in affected cells, which would 
ultimately lead to nonsense-mediated 
mRNA decay. However, there appeared 
to be little effect on other components 
of cornified envelope and desmosome 
formation (e.g., desmocollin 1, des-
moglein 1, TGM4, elafin, and LEKTI). 
Nonetheless, some increase in other 
proteins was noted (e.g., filaggrin, invo-
lucrin, lori crin, and TG1).
Israeli and colleagues confirm 
the involvement of the CDSN gene 
in generalized PSS. They stud-
ied a four-generation family with a 
consanguineous union producing two 
siblings with PSS and three unaffected 
siblings. Sequencing of the entire 
CDSN gene including all intron–exon 
boundaries revealed a homozygous 
single nucleo tide deletion in the center 
of exon 2 (c.746delG), which caused a 
pre mature stop codon 40 bases down-
stream (p.G249VfsX40). This would 
truncate the mature protein, which 
would be missing the whole C-terminal 
region (about 40% of total length 
missing). Whether this would cause 
non-sense-mediated mRNA decay is 
debatable, but a severely truncated 
protein would doubtless result.
noninflammatory generalized PSS
The third major form of PSS is the non-
inflammatory generalized type A. To 
date there have been no published 
molecular genetic studies on fami-
lies with this condition. Thus, whether 
defects in TGM5, CDSN, or SPINK5 
contribute to this form of PSS is cur-
rently unknown and will only become 
apparent after genome-wide screening 
of suitable families.
corneodesmosomes and cDSn
The term corneodesmosome was 
first proposed 20 years ago in a study 
to produce monoclonal antibodies 
to skin proteins (Serre et al., 1991). 
Human plantar stratum corneum was 
used to immunize BALB/c mice, and 
625 hybridoma supernatants were 
screened. Several monoclonal anti-
sera to epidermal keratins were identi-
fied and two others were reactive with 
the epidermis, hard palate, and inner 
root sheath of the anagen hair follicle. 
One of these antisera (G36-19) showed 
particular affinity for the stratum granu-
losum, and immuno fluorescence 
detection indicated the antigen was 
associated with the cell periphery. 
Immunogold EM labeling showed a 
strong assoc iation with desmosomes 
in the granular layer and stratum 
corneum, whereas immuno blotting 
showed reactivity to five proteins rang-
ing in mole cular weight from 33.5 to 
52 kDa. These investigators suggested 
that the described antigens participated 
in a corneodesmosome cross-linked 
envelope superstructure that aided 
corneocyte cohesiveness.
Two years later, Zhou and Chaplin 
(1993) identified a skin-associated gene 
(termed the S-gene) in the HLA class I 
region. This gene contained two exons 
and produced two transcripts (2.2 
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and 2.6 kb) that were associated with 
differentiating keratinocytes. The pro-
teins had high levels of glycine, serine, 
and proline and shared some sequence 
similarity to loricrin and the differenti-
ated keratins (K1 and K10). It became 
apparent that the product of the S-gene 
was corneodesmosin, and more exten-
sive studies followed (Simon et al., 
1997; Jonca et al., 2002). This protein 
exists in the extracellular portion of 
corneocyte desmosomes (corneodes-
mosomes), and its proteolysis from 52 
to 33 kDa is thought to be a prerequi-
site for the process of desquamation. 
Corneodesmosin is a basic (pI = 8) 
phosphoprotein that is N-glycosylated 
and cross-linked to the cornified enve-
lope of corneocytes. It has N-terminal 
glycine and serine loops similar in 
structure to those found in loricrin, K1, 
and K10, which provide homophilic 
adhesive properties (Caubet et al., 
2004).
cDSn and the hair follicle
Corneodesmosin is also found in the 
inner root sheath of hair follicles, and a 
4.2-kb region of upstream sequence was 
able to direct site-specific expression in 
both hair follicles and hyperkeratotic 
epidermis of transgenic mice (Gallinaro 
et al., 2004). This did not, however, 
provide sufficient information to direct 
expression in normal human epidermis. 
Furthermore, CDSN mutations have 
been identified in patients with auto-
somal dominant hypotrichosis simplex 
(OMIM 146520; Levy-Nissenbaum et 
al., 2003), and it is curious that similar 
CDSN gene mutations (p.Q215X and 
p.Q200X) should produce a different 
phenotype from the mutations found in 
PSS (p.K59X and p.G249VfsX40).
One possible explanation is that in 
the hypotrichosis patients, truncated 
CDSN aggregates detected in the super-
ficial dermis and hair follicles produced 
a dominant negative effect on the cells 
of the hair follicle but little effect on 
the epidermal corneocytes. One of the 
PSS mutations (p.K59X) was shown to 
be susceptible to mRNA decay and in 
homozygotes would lead to an absence 
of CDSN, which would appear to be 
more critical for the corneocyte than 
the hair follicle. The other PSS mutation 
causes premature termination much 
further along the CDSN molecule, may 
not be susceptible to mRNA decay, and 
only seems to have a skin phenotype. 
These complex genotype–phenotype 
relationships are not uncommon, and 
more research is required to further 
understand how specific gene muta-
tions exert their effect.
However, the importance of CDSN 
to both the epidermis and the hair fol-
licle becomes clear in knockout mice. 
The use of K14 promoter-driven Cre-
mediated Cdsn deletion in mice result-
ed in neonatal death, but grafting of the 
knockout mouse skin onto nude mice 
showed that the absence of corneodes-
mosin resulted in epidermal and hair 
follicle degeneration and a lethal bar-
rier defect (Leclerc et al., 2009).
cDSn, LeKtI, and nS
As well as an overlap in diagnosis of 
patients with PSS and NS, there appear 
to be interactions between the molecules 
involved in these two conditions. NS is 
caused by SPINK5 mutations, and this 
gene encodes a serine protease inhibitor 
called LEKTI. It appears that in Spink5-/- 
(KO) mice, the lack of LEKTI causes 
corneodesmosin to undergo premature 
degradation in the stratum corneum, 
resulting in epidermal detachment due 
to desmosomal destabilization (Yang 
et al., 2004). Thus, some aspects of the 
phenotype observed in NS are prob-
ably a consequence of reduced levels of 
corneodesmosin, as found in some types 
of PSS. Israeli and colleagues clearly 
point this out and also state that they 
have patients with a similar phenotype 
that do not appear to have mutations in 
either CDSN or SPINK5.
cDSn, SPr1, SeeK1, and psoriasis
The PSORS1 locus in the HLA Class 
I region encompasses two genes on 
one DNA strand (CDSN, originally 
called the S-gene, and SPR1) and a 
single gene (SEEK1) on the opposing 
strand. Both corneodesmosin and the 
small proline-rich proteins are directly 
involved in the late stages of terminal 
differentiation of the epidermis, but the 
function of the SEEK1 gene appears less 
clear. Although this region has shown 
variable levels of linkage to psoriasis 
(Tazi-Ahnini et al., 1999; Holm et al., 
2003), it is tempting to speculate that 
alter ations in either of the two genes 
involved in terminal differentiation 
of the epidermis could modulate the 
effectiveness of the barrier and the level 
of cohesiveness between corneocytes 
in an active psoriatic lesion.
conclusion
Israeli and colleagues’ letter confirming 
that mutations in the corneodesmosin 
gene are causal in PSS has shed further 
light on this single structural protein 
and has provided further insight into 
the complex relationships between the 
genotype and phenotype of cutaneous 
genodermatoses. It also highlights the 
fact that a single protein can influence 
the physiology and function of a tissue 
in different ways.
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